Patricia Troncoso, MD

Patricia Troncoso, MD, is a Professor at The University of Texas MD Anderson Cancer Center, where she specializes in genitourinary pathology and prostate cancer research. Her work integrates clinical oncology, radiation oncology, and pharmacology to advance treatment paradigms for prostate and other genitourinary cancers. Recent contributions include leading a phase Ib trial of nezastomig plus cemiplimab in metastatic castration-resistant prostate cancer, co-authoring the randomized EXTEND trial on metastasis-directed therapy for oligometastatic disease, and evaluating long-term outcomes of hypofractionated radiation. She has also published on prostate pathology reporting standards and post-radiation urethral adenocarcinoma, reflecting her dual expertise in translational therapeutics and diagnostic precision.